EXE vs. WELL, DNTL, SIA, DR, KDA, NLH, PHA, BHC, BLU, and TRIL
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include WELL Health Technologies (WELL), dentalcorp (DNTL), Sienna Senior Living (SIA), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), Bausch Health Companies (BHC), BELLUS Health (BLU), and Trillium Therapeutics (TRIL). These companies are all part of the "medical" sector.
Extendicare vs.
Extendicare (TSE:EXE) and WELL Health Technologies (TSE:WELL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation.
WELL Health Technologies has a net margin of 7.67% compared to Extendicare's net margin of 4.48%. Extendicare's return on equity of 64.13% beat WELL Health Technologies' return on equity.
Extendicare presently has a consensus price target of C$10.25, suggesting a potential downside of 10.48%. WELL Health Technologies has a consensus price target of C$8.75, suggesting a potential upside of 42.97%. Given WELL Health Technologies' stronger consensus rating and higher probable upside, analysts plainly believe WELL Health Technologies is more favorable than Extendicare.
19.2% of Extendicare shares are held by institutional investors. Comparatively, 5.6% of WELL Health Technologies shares are held by institutional investors. 13.9% of Extendicare shares are held by company insiders. Comparatively, 6.8% of WELL Health Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Extendicare has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, WELL Health Technologies has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.
In the previous week, Extendicare had 3 more articles in the media than WELL Health Technologies. MarketBeat recorded 6 mentions for Extendicare and 3 mentions for WELL Health Technologies. Extendicare's average media sentiment score of 0.99 beat WELL Health Technologies' score of 0.66 indicating that Extendicare is being referred to more favorably in the media.
Extendicare received 111 more outperform votes than WELL Health Technologies when rated by MarketBeat users. However, 57.14% of users gave WELL Health Technologies an outperform vote while only 47.63% of users gave Extendicare an outperform vote.
WELL Health Technologies has lower revenue, but higher earnings than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Extendicare beats WELL Health Technologies on 10 of the 17 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Extendicare Competitors List
Related Companies and Tools
This page (TSE:EXE) was last updated on 2/22/2025 by MarketBeat.com Staff
